Improving use of proton pump inhibitors with dual antiplatelet therapy in patients admitted with acute coronary syndrome
{{output}}
Acute coronary syndrome (ACS) is one of the leading causes of morbidity and mortality with a major impact on healthcare resources and expenditure. Dual antiplatelet therapy (DAPT) is recommended for the treatment of ACS. DAPT is associated with an increased ri... ...
